DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Esab India vs Nifty 50: Share Price Performance Compared

Univest 11 hrs ago·17 Sept 2026, 12:29 pm

Esab India has recently outperformed the benchmark Nifty 50 index, delivering stronger returns to its shareholders. This divergence highlights the company's relative strength compared to the broader market, driven by its focus on capital goods and industrial tools.

For investors, this performance suggests that Esab India may be gaining traction in its sector. It reflects investor confidence in its business model and operational efficiency, which could be a positive signal for those tracking the company's growth trajectory.

Moving forward, investors should monitor the company's quarterly results and the overall industrial demand. Any further outperformance or underperformance against the Nifty 50 will provide more clarity on its current market standing.